Survival Analysis
In this panel, you can perform survival analysis based on the expression status of one gene or a multi-genes' signature and plot a Kaplan-Meier curve. Some gene signature lists are provided.
GEPIA performs Overall Survival (OS) or Progression-free Interval (PFI) analysis based on gene expression `log2 (TPM+1)` transformed. GEPIA uses Log-rank test, a.k.a the Mantel-Cox test, for hypothesis test. Cohorts thresholds can be adjusted. The cox proportional hazard ratio and the 95% confidence interval information can also be included in the survival plot.
Parameters:
- Gene: Input a gene/isoform or gene signature of interest
- Time Response: Select the OS or PFS survival response.
- Axis Units: Select Month or Day unit for plotting.
- Datasets Selection: Select one or multiple cancer types of interest in the "Dataset" field and click "+" to build dataset list in the "Selected Datasets" field.
- Colors: Choose color to plot
- Group Cutoff: Select a suitable expression threshold for splitting the high-expression and low-expression cohorts.
- Cutoff-High(%): Samples with expression level higher than this threshold are considered as the high-expression cohort.
- Cutoff-Low(%): Cutoff-Low(%): Samples with expression level lower than this threshold are considered the low-expression cohort.
TCGA Abbr.
Abbr | Detail |
---|---|
ACC | Adrenocortical carcinoma |
BLCA | Bladder Urothelial Carcinoma |
BRCA | Breast invasive carcinoma |
CESC | Cervical squamous cell carcinoma and endocervical adenocarcinoma |
CHOL | Cholangiocarcinoma |
COAD | Colon adenocarcinoma |
DLBC | Lymphoid Neoplasm Diffuse Large B-cell Lymphoma |
ESCA | Esophageal carcinoma |
GBM | Glioblastoma multiforme |
HNSC | Head and Neck squamous cell carcinoma |
KICH | Kidney Chromophobe |
KIRC | Kidney renal clear cell carcinoma |
KIRP | Kidney renal papillary cell carcinoma |
LAML | Acute Myeloid Leukemia |
LGG | Brain Lower Grade Glioma |
LIHC | Liver hepatocellular carcinoma |
LUAD | Lung adenocarcinoma |
LUSC | Lung squamous cell carcinoma |
MESO | Mesothelioma |
OV | Ovarian serous cystadenocarcinoma |
PAAD | Pancreatic adenocarcinoma |
PCPG | Pheochromocytoma and Paraganglioma |
PRAD | Prostate adenocarcinoma |
READ | Rectum adenocarcinoma |
SARC | Sarcoma |
SKCM | Skin Cutaneous Melanoma |
STAD | Stomach adenocarcinoma |
TGCT | Testicular Germ Cell Tumors |
THCA | Thyroid carcinoma |
THYM | Thymoma |
UCEC | Uterine Corpus Endometrial Carcinoma |
UCS | Uterine Carcinosarcoma |
UVM | Uveal Melanoma |
License Statement: All content on this website is freely available to all users, including for commercial use.